natgillin/translations-raw huggingface dataset:
Do not use this medicine if you notice any visible signs of deterioration, if the liquid contains particles or is not clear. 
Ne uporabljajte tega zdravila, če opazite kakršne koli vidne znake kvarjenja, če tekočina vsebuje delce ali ni bistra.
Clinical efficacy and safety in women 
Klinična učinkovitost in varnost pri ženskah
This is when your follicles develop too much and become large cysts. 
To pomeni, da se folikli preveč razvijejo in postanejo velike ciste.
It is not yet established whether or not treatment with gonadotropins increases the risk of these tumours in infertile women. 
Ni pa še ugotovljeno, ali zdravljenje z gonadotropini povečuje tveganje za tovrstne tumorje pri neplodnih ženskah.
If you are not ovulating, have no periods and have been diagnosed with very low levels of FSH and LH hormones 
Če nimate ovulacije, nimate menstruacije in imate diagnozo zelo nizkih ravni hormonov FSH in
Perform the injection every day around the same time. 
Injiciranje opravite vsak dan ob približno istem času.
The prevalence of congenital malformations after ART may be slightly higher than after spontaneous conceptions. 
Prevalenca prirojenih malformacij po ART je lahko rahlo večja kot pri spontanih zanositvah.
• If you administer Bemfola to yourself, please carefully read and follow the “Instructions for Use”. 
• Če si zdravilo Bemfola dajete sami, skrbno preberite in upoštevajte poglavje „Navodila za uporabo“.
• you have stomach, arm or leg pain. 
• imate bolečine v želodcu, rokah ali nogah.
If after this period, the patient has not responded, the combination treatment may be continued; current clinical experience indicates that treatment for at least 18 months may be necessary to achieve spermatogenesis. 
Če po tem obdobju ni odziva pri bolniku, se lahko zdravljenje s kombinacijo nadaljuje; sedanje klinične izkušnje kažejo, da je lahko za doseganje spermatogeneze potrebnih vsaj 18 mesecev.
Pharmacotherapeutic group: Sex hormones and modulators of the genital systems, gonadotropins, ATC code: G03GA05. 
Farmakoterapevtska skupina: spolni hormoni in zdravila za uravnavanje delovanja spolovil, gonadotropni hormoni, oznaka ATC: G03GA05.
• if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine (listed in section 6). 
- če ste alergični na folikle stimulirajoči hormon ali katero koli sestavino tega zdravila (navedeno v poglavju 6);
In women with recent or ongoing thromboembolic disease or women with generally recognised risk factors for thromboembolic events, such as personal or family history, treatment with gonadotropins may further increase the risk for aggravation or occurrence of such events. 
Pri ženskah z nedavnimi ali potekajočimi trombemboličnimi boleznimi ali pri ženskah s splošno znanimi dejavniki tveganja za trombembolične dogodke, kot je osebna ali družinska anamneza, lahko zdravljenje z gonadotropini še poveča tveganje za poslabšanje ali pojav teh dogodkov.
• primary testicular insufficiency. 
• primarna insuficienca testisov.
• You will use these two medicines each day for up to five weeks. 
• Ti dve zdravili boste naslednjih pet tednov uporabljali vsak dan.
Men with too much FSH in their blood 
Moški, ki imajo v krvi previsoko raven FSH
Self-administration of Bemfola should only be performed by patients who are well motivated, adequately trained and have access to expert advice. 
Zdravilo Bemfola si lahko sami dajejo le tisti bolniki, ki so dobro motivirani, ustrezno poučeni in imajo možnost posvetovati se s strokovnjakom.
• Serious blood clotting complications (thromboembolic events) sometimes independent of OHSS may be found very rarely (may affect up to 1 in 10,000 people). 
• Resni zapleti zaradi krvnih strdkov (trombembolični dogodki), včasih neodvisni od OHSS, so zelo redki (pojavijo se lahko pri do 1 bolniku od 10.000).
You can reduce the risk of multiple pregnancy by using the right dose of Bemfola at the right times. 
Tveganje večplodne nosečnosti lahko zmanjšate tako, da ob pravem času uporabite pravi odmerek zdravila Bemfola.
These instructions can be found at the end of the package leaflet. 
Ta navodila najdete na koncu navodila za uporabo.
Gonadotropin therapy requires a certain time commitment by physicians and supportive health professionals, as well as the availability of appropriate monitoring facilities. 
Zdravljenje z gonadotropinom zahteva od zdravnika in drugega zdravstvenega osebja določen čas ter tudi razpoložljivost ustrezne opreme za nadzorovanje zdravljenja.
This side effect is very rare 
Ta neželeni učinek je zelo redek.
Patients must be provided with the correct number of pens for their treatment course and educated to use the proper injection techniques. 
Bolnikom je treba dati pravilno število injekcijskih peresnikov za potek zdravljenja in jih naučiti pravilnih tehnik injiciranja.
Therefore, it is considered appropriate to give a lower total dose of follitropin alfa than generally used for urinary FSH, not only in order to optimise follicular development but also to minimise the risk of unwanted ovarian hyperstimulation (see section 5.1). 
Zato je primerno, da predpišemo nižji skupni odmerek folitropina alfa, kot se običajno uporablja za urinarni FSH, ne samo za čim boljši razvoj foliklov, ampak tudi zato, da čim bolj zmanjšamo tveganje za neželeno hiperstimulacijo jajčnikov (glejte poglavje 5.1).
In menstruating women treatment should commence within the first 7 days of the menstrual cycle. 
Pri ženskah, ki imajo menstruacijo, se mora zdravljenje pričeti v prvih 7 dneh menstrualnega ciklusa.
• The numbers on the dose display are measured in International Units or IU. 
• Številke v prikazu odmerka so v mednarodnih enotah ali i.e.
You should also hear a click, and some liquid will splash out (this is normal).The pen is now ready to set the dose. 
Slišali boste tudi klik in nekaj tekočine se bo iztisnilo (to je normalno).
• Your doctor/pharmacist will tell you how many Bemfola pens you need to use for your complete treatment course. 
• Vaš zdravnik/farmacevt vam bo povedal, koliko injekcijskih peresnikov Bemfola potrebujete za celoten potek zdravljenja.
If severe OHSS occurs, it is recommended that gonadotropin treatment be stopped if still ongoing, and that the patient be hospitalised and appropriate therapy be started. 
Če se pojavi hud OHSS, je priporočljivo zdravljenje z gonadotropinom ukiniti, če to še traja, bolnico sprejeti v bolnišnico in začeti ustrezno zdravljenje
Women 
Ženske
• Bemfola dose may be increased, depending on your response. 
• Odmerek zdravila Bemfola se lahko zviša glede na vaš odziv.
This gets your eggs ready for collection. 
To jajčeca pripravi na odvzem.
The maximal daily dose is usually not higher than 225 IU FSH. 
Največji dnevni odmerek običajno ni večji od 225 i.e. FSH.
In ART, aspiration of all follicles prior to ovulation may reduce the occurrence of hyperstimulation. 
Pri ART lahko aspiracija vseh foliklov pred ovulacijo zmanjša pojavnost hiperstimulacije.
The lowest effective dose in relation to the treatment objective should be used in both men and women. 
Pri moških in ženskah se mora uporabiti najmanjši še učinkoviti odmerek glede na namen zdravljenja.
Elderly population 
Posebne populacije Starejša populacija
For accurate interpretation of the indices of follicle development and maturation, the physician should be experienced in the interpretation of the relevant tests. 
Za pravilno tolmačenje kazalcev folikularnega razvoja in dozorevanja mora imeti zdravnik izkušnje na področju tolmačenja tovrstnih testov.
If you are developing OHSS your doctor may not give you any hCG in this treatment cycle and you may be told not to have sex or to use a barrier contraceptive method for at least four days. 
Če se razvije OHSS, vam zdravnik ne sme dati hCG v tem ciklusu zdravljenja in vam utegne naročiti, da najmanj štiri dni ne smete imeti spolnih odnosov ali da morate uporabljati mehanska kontracepcijska sredstva.
A certain degree of ovarian enlargement is an expected effect of controlled ovarian stimulation. 
Določena stopnja povečanja jajčnikov je pričakovan učinek nadzorovane stimulacije jajčnikov.
Adherence to the recommended follitropin alfa dose and to the regimen of administration can minimise the risk of ovarian hyperstimulation (see sections 4.2 and 4.8). 
Upoštevanje priporočenega odmerka folitropina alfa in režima uporabe lahko zmanjša tveganje hiperstimulacije jajčnikov (glejte poglavji 4.2 in 4.8).
The pH of the solution is 6.7 - 7.3. 
pH raztopine je od 6,7 do 7,3.
• If you have irregular periods, start using Bemfola within the first 7 days of your menstrual cycle. 
• Če imate neredne menstruacije, začnite uporabljati zdravilo Bemfola v prvih sedmih dni vašega menstruacijskega ciklusa.
BATCH NUMBER<, DONATION AND PRODUCT CODES> Lot 
ŠTEVILKA SERIJE<, ENOTNE OZNAKE DAROVANJA IN IZDELKOV> Lot
Mild or moderate OHSS usually resolves spontaneously. 
Blag do zmeren OHSS običajno izzveni spontano.
Gently tap the pen so that any large air bubbles rise to the top. 
Rahlo potrkajte po injekcijskem peresniku, da se morebitni veliki zračni mehurčki dvignejo na vrh.
If you are not ovulating and have irregular or no periods 
Če nimate ovulacije in imate neredne menstruacije ali menstruacij nimate
In women, FSH is needed for the growth and development of the sacs (follicles) in the ovaries that contain the egg cells. 
Ženske potrebujejo FSH za rast in razvoj foliklov v jajčnikih, ki vsebujejo jajčne celice.
Treatment in men 
Zdravljenje moških
Mild to severe hypersensitivity reactions including anaphylactic reactions and shock 
blage do hude preobčutljivostne reakcije, vključno z anafilaktičnimi reakcijami in šokom
The used pen needs to be discarded in a sharps container and returned to the pharmacy for a correct disposal. 
Uporabljen injekcijski peresnik je treba zavreči v posodo za ostre predmete in jo vrniti v lekarno, kjer bodo poskrbeli za pravilno odstranjevanje.
What you need to know before you use Bemfola 
Kaj morate vedeti, preden boste uporabili zdravilo Bemfola
• malformations of sexual organs incompatible with pregnancy; 
• malformacije spolnih organov, ki niso združljive z nosečnostjo;
The first injection of Bemfola should be performed under direct medical supervision. 
Injiciranje prve injekcije zdravila Bemfola se mora izvesti pod neposrednim zdravniškim nadzorom.
It is more commonly seen in women with polycystic ovarian syndrome and usually regresses without treatment. 
Pogosteje nastopi pri ženskah s sindromom policističnih jajčnikov in običajno izzveni brez zdravljenja.
Once opened, the medicine should be injected immediately. 
Ko zdravilo odprete, ga je treba injicirati takoj.
Ask your pharmacist how to dispose of medicines you no longer use. 
O načinu odstranjevanja zdravila, ki ga ne uporabljate več, se posvetujte s farmacevtom.
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially “sodiumfree”. 
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni „brez natrija“.
• Swelling of the veins above and behind the testicles (varicocele). 
• oteklost žil nad testisi in za njimi (varikokela);
This may indicate that the ovaries over-reacted to the treatment and that large ovarian cysts developed (see also section 2 “Take special care with Bemfola”). 
Lahko kažejo na to, da so se jajčniki premočno odzvali na zdravljenje in so se razvile velike ciste na jajčnikih (glejte tudi poglavje 2 „Bodite posebno pozorni pri uporabi zdravila Bemfola“).
Other medicines and Bemfola 
Druga zdravila in zdravilo Bemfola
Nevertheless one could expect Ovarian HyperStimulation Syndrome (OHSS) to occur, which is described in section 4. 
Vendar lahko pričakujemo pojav sindroma hiperstimulacije jajčnikov (Ovarian Hyper-Stimulation Syndrome - OHSS), ki je podrobno opisan v poglavju 4.
• if you have a tumour in your hypothalamus or pituitary gland (both are parts of the brain). 
- če imate tumor hipotalamusa ali hipofize (oboje je del možganov).
Treatment should be initiated under the supervision of a physician experienced in the treatment of fertility disorders. 
Zdravljenje se mora pričeti pod nadzorom zdravnika, ki ima izkušnje z zdravljenjem motenj plodnosti.
Deterioration or a first appearance of this condition may require cessation of treatment. 
Poslabšanje ali prvi pojav porfirije lahko povzroči, da je treba zdravljenje prekiniti.
Patients with porphyria or a family history of porphyria should be closely monitored during treatment with follitropin alfa. 
Bolnike s porfirijo ali porfirijo v družinski anamnezi je treba med zdravljenjem s folitropinom alfa skrbno nadzorovati.
Treatment in women 
Zdravljenje žensk
In distinction to uncomplicated ovarian enlargement, OHSS is a condition that can manifest itself with increasing degrees of severity. 
Za razliko od povečanja jajčnikov brez zapletov je OHSS zdravstveno stanje, ki se lahko izrazi z naraščajočo stopnjo resnosti.
A commonly used regimen commences at 75-150 IU FSH daily and is increased preferably by 37.5 or 75 IU at 7 or preferably 14 day intervals if necessary, to obtain an adequate, but not excessive, response. 
Režim, ki se običajno uporablja, se prične z odmerkom 75-150 i.e. FSH na dan, tega pa je treba po potrebi povečevati za 37,5 ali 75 i.e. v 7- ali najbolje v 14-dnevnih razmikih za doseganje zadostnega, a ne pretiranega odziva.
As the Bemfola pre-filled pen with the single-dose cartridge is intended for only one injection, clear instructions should be provided to the patients to avoid misuse of the single dose presentation. 
Ker je zdravilo Bemfola napolnjen injekcijski peresnik z enoodmernim vložkom namenjeno samo enkratnemu injiciranju, mora dobiti bolnik jasna navodila za uporabo, v izogib napačni uporabi enoodmerne oblike zdravila.
A recommended regimen commences at 75 IU of lutropin alfa daily with 75-150 IU FSH. 
Priporočeni režim se začne s 75 i.e. lutropina alfa na dan skupaj s 75-150 i.e. FSH.
If you get lower abdominal pain, gain any weight rapidly, feel sick or are vomiting or if you have difficulty in breathing, talk to your doctor straight away who might ask you to stop using this medicine (see section 4). 
Če se pojavijo bolečine v spodnjem delu trebuha, če hitro pridobivate telesno maso, če vam je slabo ali bruhate ali imate težave z dihanjem, se takoj pogovorite z zdravnikom, ki vam utegne priporočiti prekinitev zdravljenja (glejte poglavje 4).
• Your doctor or nurse will show you how to use the Bemfola pre-filled pen to inject the medicine. 
• Vaš zdravnik ali medicinska sestra vam bosta pokazala, kako se uporablja napolnjen injekcijski peresnik za injiciranje zdravila Bemfola.
When GnRH antagonist is used, it is administered from the 5th or 6th day of Bemfola treatment and continued until ovulation induction. 
Pri uporabi antagonista GnRH se ta daje 5. ali 6. dan zdravljenja z zdravilom Bemfola in se nadaljuje do indukcije ovulacije.
In a commonly used protocol, follitropin alfa is started approximately 2 weeks after the start of agonist treatment, both being continued until adequate follicular development is achieved. 
Po protokolu, ki se splošno uporablja, se zdravljenje s folitropinom alfa začne približno dva tedna po začetku zdravljenja z agonistom in se nadaljuje z dajanjem obeh zdravil, dokler ni dosežen zadosten folikularni razvoj.
To minimise the risk of multiple pregnancy, careful monitoring of ovarian response is recommended. 
Za zmanjšanje tveganja večplodne nosečnosti se priporoča skrbno spremljanje ovarijskega odziva.
Elevated endogenous FSH levels are indicative of primary testicular failure. 
Povišane vrednosti endogenega FSH kažejo na primarno odpoved testisov.
If you forget to use Bemfola 
Če ste pozabili uporabiti zdravilo Bemfola
Bemfola is a biosimilar medicinal product. 
Zdravilo Bemfola je biološko podobno zdravilo.
Note: The pen is now ready for injection. 
Opomba: injekcijski peresnik je zdaj pripravljen za uporabo.
In case you are not ovulating, and if the recommended dose and schedule of administration are adhered to, the occurrence of OHSS is less likely. 
Če nimate ovulacije in upoštevate priporočeni odmerek in shemo dajanja zdravila, je manj verjetno, da bi se pojavil OHSS.
• OHSS may become severe with clearly enlarged ovaries, decreased urine production, weight gain, difficulty in breathing and/or possible fluid accumulation in your stomach or chest. 
• OHSS lahko postane resen z izrazito povečanimi jajčniki, zmanjšanim nastajanjem urina, pridobivanjem telesne mase, težavami dihanja in/ali morebitnim nabiranjem tekočine v trebuhu ali prsnem košu.
3 years Once opened, the medicinal product should be injected immediately. 
3 leta Ko zdravilo odprete, ga je treba injicirati takoj.
Using this medicine 
Uporaba tega zdravila
• Lower abdominal pain together with nausea or vomiting may be the symptoms of Ovarian Hyper-Stimulation Syndrome (OHSS). 
• Bolečina v spodnjem delu trebuha skupaj s slabostjo ali bruhanjem so lahko simptomi sindroma hiperstimulacije jajčnikov (OHSS).
Multiple pregnancy, especially of high order, carries an increased risk of adverse maternal and perinatal outcomes. 
Večplodna nosečnost, zlasti visokega reda, pomeni povečano tveganje za neželen perinatalni izid in neželen izid za mater.
In women, safe and effective use of follitropin alfa calls for monitoring of the ovarian response with ultrasound, alone or preferably in combination with measurement of serum estradiol levels, on a regular basis. 
Pri ženskah je za varno in učinkovito uporabo folitropina alfa potrebno redno nadzorovanje odziva jajčnikov z ultrazvokom ali še bolje z ultrazvokom v kombinaciji z merjenjem serumskih ravni estradiola.
Do not remove the needle immediately, wait for 5 seconds, before pulling it out. 
Počakajte 5 sekund, preden jo izvlečete.
Ovarian Hyperstimulation Syndrome (OHSS) 
Sindrom hiperstimulacije jajčnikov (OHSS)
The adverse reactions are ranked under heading of frequency using the following convention: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000). 
Seznam neželenih učinkov Neželeni učinki so razvrščeni pod navedbo pogostnosti, ki je določena po naslednjih kriterijih: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000).
Mild or moderate ovarian hyperstimulation syndrome (OHSS) has been commonly reported and should be considered as an intrinsic risk of the stimulation procedure. 
Pogosto so poročali o blagem ali zmernem sindromu hiperstimulacije jajčnikov (OHSS), ki ga je treba obravnavati kot tveganje, značilno za postopek stimulacije.
• Only use this pen for you - do not let anyone else use it. 
• Injekcijski peresnik je samo za vašo uporabo, zato ga ne sme uporabljati nihče drug.
Follitropin alfa should be given as a course of daily injections simultaneously with lutropin alfa. 
Folitropin alfa se mora dajati kot zaporedje vsakodnevnih injekcij sočasno z lutropinom alfa.
Data on a limited number of exposed pregnant women (less than 300 pregnancy outcomes) indicate no malformative or feto/neonatal toxicity of follitropin alfa. 
Podatki omejenega števila izpostavljenih nosečnici (manj kot 300 izidov nosečnosti) ne kažejo na malformacijsko ali feto/neonatalno toksičnost folitropina alfa.
The effects of an overdose of follitropin alfa are unknown, nevertheless, there is a possibility that OHSS may occur (see section 4.4). 
Učinki prevelikega odmerka folitropina alfa niso znani, vendar obstaja možnost, da se pojavi OHSS (glejte poglavje 4.4).
Alternatively, intrauterine insemination may be performed by placing the sperm into the womb cavity. 
Druga možnost je intrauterina oploditev z vnosom sperme v maternično votlino.
In other cases, your doctor may first stop you from ovulating by using a gonadotropin-releasing hormone (GnRH) agonist or antagonist. 
V drugih primerih lahko zdravnik najprej ustavi ovulacijo z dajanjem agonista ali antagonista gonadotropin sproščujočega hormona (GnRH).
Caution: 
Pozor:
Semen analysis is recommended 4 to 6 months after the beginning of treatment as part of the assessment of the response. 
Kot del ocenjevanja odziva se priporoča analiza semenske tekočine štiri do šest mesecev po začetku zdravljenja.
If you had in the past or recently blood clots in the leg or in the lung, or a heart attack or stroke, or if those happened in your family, then you might have a higher risk that these problems occur or become worse with Bemfola treatment. 
Težave s strjevanjem krvi (trombembolični dogodki) Če ste pred kratkim ali v preteklosti imeli krvne strdke v nogah ali pljučih, srčni napad ali kap, ali če se je to zgodilo kakemu družinskemu članu, je morda pri vas večje tveganje, da se te težave pri zdravljenju z zdravilom Bemfola pojavijo ali poslabšajo.
• Your asthma may get worse. 
• poslabšanje astme.
4.1 Therapeutic indications 
4.1 Terapevtske indikacije Pri odraslih ženskah
However the OHSS will only occur if hCG is also administered (see section 2, under ‘OHSS'). 
OHSS se lahko pojavi samo, če se uporabi tudi hCG (glejte poglavje 2, OHSS).
• Before starting to use your pre-filled pen, please read these instructions and the package leaflet the whole way through first. 
• Preden začnete uporabljati napolnjen injekcijski peresnik, najprej v celoti preberite ta navodila in Navodilo za uporabo.
In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L. 
V kliničnih preskušanjih so bile te bolnice določene na podlagi ravni endogenega LH v serumu < 1,2 i.e./l.
If you notice any of the above-listed side effects you should immediately contact your doctor, who might ask you to stop using Bemfola. 
Če opazite katerega koli od zgoraj navedenih neželenih učinkov, se takoj posvetujte z zdravnikom, ki vam bo morda predlagal, da prenehate uporabljati zdravilo Bemfola.
The safety, efficacy and pharmacokinetics of follitropin alfa in patients with renal or hepatic impairment have not been established. 
Varnost, učinkovitost in farmakokinetika folitropina alfa pri bolnikih z ledvično ali jetrno okvaro niso bili dokazani.
In adult women, Bemfola is used: 
Pri odraslih ženskah se zdravilo Bemfola uporablja:
Your doctor will use blood tests and/or an ultrasound machine to check when this is. 
Vaš zdravnik bo s krvnimi preiskavami in/ali ultrazvočnim pregledom ugotovil nastop želenega stanja.
Follitropin alfa should be given at a dose of 150 IU three times a week, concomitantly with hCG, for a minimum of 4 months. 
Folitropin alfa se mora dajati v odmerku 150 i.e., trikrat na teden, sočasno s hCG, najmanj štiri mesece.
Such patients are unresponsive to follitropin alfa/hCG therapy. 
Takšni bolniki se na zdravljenje s folitropinom alfa/hCG ne odzivajo.
Driving and using machines It is not expected that this medicine will affect your ability to drive and use machines. 
Ne pričakuje se, da bi zdravilo vplivalo na sposobnost vožnje ali upravljanja strojev.
• Your dose of Bemfola may be increased every 7 or every 14 days by 37.5 to 75 IU, until you get the desired response. 
• Vaš odmerek zdravila Bemfola se lahko poveča vsakih 7 ali 14 dni za 37,5 do 75 i.e., dokler ne boste dosegli želenega odziva.
Before you start using your pre-filled pen 
Preden začnete uporabljati svoj napolnjeni injekcijski peresnik
• Give yourself the injection around the same time each day. 
• Zdravilo si injicirajte vsak dan ob približno istem času.
If your doctor decides to try Bemfola treatment, to monitor the treatment, they may ask you to provide semen for analysis 4 to 6 months after starting treatment. 
Če se zdravnik odloči, da vas bo poskusil zdraviti z zdravilom Bemfola, vas bo za spremljanje vašega zdravljenja štiri do šest mesecev po začetku zdravljenja prosil za vzorce sperme za analizo.
• primary ovarian failure; 
• primarna odpoved jajčnikov;
Severe OHSS (including associated symptomatology) (see section 4.4) 
hud OHSS (vključno s povezanimi simptomi) (glejte poglavje 4.4)
Use the prefilled pen only once then it should be disposed of in a safe manner. 
Napolnjeni injekcijski peresnik uporabite samo enkrat, potem pa ga na varen način zavrzite.
After the injection 
Po injiciranju
Do not use Bemfola 
Ne uporabljajte zdravila Bemfola
• gynaecological haemorrhages of unknown aetiology; 
• ginekološka krvavitev neznane etiologije;